Effects of low flow and hypoxia on myocardial retention of technetium-99m BMS181321

European Journal of Nuclear Medicine

Volumn 23, Issue 4, 1996, Pages 443-447

  Okada, Robert D ^a   Nguyen, Kiem N ^a   Strauss, H William ^b   Johnson III, Gerald ^a,c  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c William K Warren Med Res Cent   (United States)

Author keywords

BMS181321; Low flow ischemia; Myocardial clearance; Myocardial uptake

Indexed keywords

ALBUMIN; BUFFER; OXO[3,3,9,9 TETRAMETHYL 1 (2 NITRO 1H IMIDAZOL 1 YL) 4,8 DIAZAUNDECANE 2,10 DIONEDIOXIMATO]TECHNETIUM TC 99M; SODIUM IODIDE; TECHNETIUM 99M;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG TISSUE LEVEL; DRUG UPTAKE; ERYTHROCYTE; FLOW; HEART; HEART MUSCLE; HEART MUSCLE PERFUSION; HYPOXIA; ISCHEMIA; MODEL; NONHUMAN; RAT;

ANIMALS; ANOXIA; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NITROIMIDAZOLES; ORGANOTECHNETIUM COMPOUNDS; RATS; TECHNETIUM; TIME FACTORS;

EID: 0029870144     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01247374     Document Type: Article

References (9)

1. Kusuoka H, Hashimoto K, Fukuchi K, Nishimura T. Kinetics of a putative hypoxic tissue marker, technetium-99m-nitroimidazole (BMS181321), in normoxic, hypoxic, ischemic and stunned myocardium. J Nucl Med 1994; 35: 1371-1376.
2. Rumsey WL, Cyr JE, Raju N, Narra RK. A novel technetium-99m-labeled nitroheterocycle capable of identification of hypoxia in heart. Biochem Biophys Res Commun 1993; 193: 1239-1246.
3. Rumsey WL, Patel B, Linder KE. Effect of graded hypoxia on retention of technetium-99m nitroheterocycle in perfused rat heart. J Nucl Med 1995; 36: 632-636.
4. Okada RD, Nguyen K, Lauinger M, Allton IL, Spreitzer K, Beju D, Johnson G. Effects of no flow and reperfusion on kinetics of TC-Q12: a new myocardial perfusion imaging agent. J Nucl Med 1995; 36: 2103-2109.
5. Rumsey WL, Vanderkooi JM, Wilson DF. Imaging of phoshorescence: a novel method for measuring oxygen distribution in perfused tissue. Science 1988; 241: 1649-1651.
6. Stone CK, Mulnix T, Nickels RJ, Renstrom B, Nellis SH, Liedtke AJ. Specificity of regional myocardial retention of the technetium-99m nitromidazole BMS181321 during myocardial ischemia and reperfusion; lack of retention with injection in reperfusion. Circulation 1993; 90: 1-138.
7. Dahlberg ST, Gilmore MP, Flood M, Leppo JA. Effect of hypoxia and low-flow ischemia on the myocardial extraction of technetium-99m-nitroimidazole [abstract]. Circulation 1993; 88 Suppl II: I-1339.
8. Shi Q-X, Dione DP, Singer MJ, Heller E, Young L, Wackers FJT, Zaret BL, Sinusas AJ. Technetium-99m-nitroimidazole: a positive imaging agent for the detection of myocardial ischemia [abstract]. Circulation 1993; 88 Suppl II: I-249.
9. Ng CK, Sinusas AJ, Zaret BL, Soufer R. Kinetic analysis of technetium-99m labeled nitroimidazole (BMS181321), a marker for hypoxic myocardium [abstract]. J Am Coll Cardiol 1994; 343A(787-4).